China's CanSino Biologics (CanSinoBIO) may start as early as next month a clinical trial using Russia's Sputnik V vaccine followed by a shot of its own Covid-19 vaccine, a senior executive said late on Thursday.

Combined dosage may help address a global shortage of the two-dose Sputnik V, which adopts a similar technique as the Chinese...